Matthew Ehrhardt News Today

Recent research determined that two specific biomarkers may help predict and protect survivors of childhood cancer from heart risks, such as cardiomyopathy.

Data from the St. Jude lifetime cohort study (St. Jude LIFE) revealed that two common biomarkers of cardiac function and damage could better predict cardiomyopathy within five years than routine clinical evaluations in high-risk, asymptomatic childhood cancer survivors.

Scientists at St. Jude Children’s Research Hospital found that two common biomarkers could predict cardiomyopathy that is otherwise undetected by conventiona

More childhood cancer survivors are growing up to become adults with health issues. Experts are calling attention to their care.

More childhood cancer survivors are growing up to become adults with health issues. Experts are calling attention to their care.

Dr Ehrhardt discusses how modifiable chronic health conditions may relate to social determinants of health, noting how these factors can potentially lead to late mortality for survivors of childhood cancer.

A report from the Childhood Cancer Survivor Study provides strong evidence of the importance of a healthy lifestyle for adults who were treated for cancer as children.

St. Jude Children's Research Hospital scientists have found that socioeconomic deprivation, the presence of treatable chronic health conditions and frailty are independently associated with increased late mortality in childhood cancer survivors.

Date Time Excellent outcomes reported for first targeted frontline therapy for high-risk pediatric Hodgkin lymphoma (From left) First and corresponding author Monika Metzger, M.D., Departments of Oncology and Global Pediatric Medicine; co- senior author Matthew Krasin, M.D., Department of Radiation Oncology; and co-senior author Melissa Hudson, M.D., Cancer Survivorship Division director. Scientists are reporting results of the first frontline clinical trial to use targeted therapy to treat hig...